Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study
Labetoulle M., Leonardi A., Amrane M., Ismail D., Garrigue J.-S., Garhöfer G., de la Maza M.S., Baudouin C.
View publication
-
Therapeutic Area
Front of the eye (FOTE)
-
Technology
Drug Delivery
-
Categories
Clinical development
-
Affiliations
Department of Ophthalmology, Bicêtre Hospital, AP-HP, Paris-Sud University, Le Kremlin-Bicêtre, France; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Santen SAS, Evry, France; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; Institute Clinic of Ophthalmology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Quinze-Vingts National Ophthalmology Hospital, Paris, France; UPMC University, Paris 6, Vision Institute, INSERM UMRS968, CNRS UMR7210, Paris, France; University of Versailles Saint-Quentin en Yvelines, Versailles, France